Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
METHOD FOR MEASURING OCCUPANCY RATE OF SPECIFIC BINDING SUBSTANCES IN CELL POPULATION
Document Type and Number:
WIPO Patent Application WO/2019/031444
Kind Code:
A1
Abstract:
Provided is a method for measuring the occupancy rate of a first specific binding substance in a cell population, the method including causing the cell population to come into contact with second and third specific binding substances, and measuring the number of cells to which the second and third specific binding substances are bonded, wherein the first, second, and third specific binding substances all bond to a target cell surface protein, the occupancy rate is the proportion of cells, from among cells expressing the target cell surface protein, to which the first specific binding substance binds, the second specific binding substance competes with the first specific binding substance, the third specific binding substance does not compete with the first specific binding substance, and the occupancy rate (%) is the value calculated by the formula: (1- (the number of cells to which the second specific binding substance is bonded/the number of the cells to which the third specific binding substance is bonded)) × 100.

Inventors:
MATSUMOTO KOICHIRO (JP)
YANAGIHARA TOYOSHI (JP)
TANAKA KENTARO (JP)
Application Number:
PCT/JP2018/029390
Publication Date:
February 14, 2019
Filing Date:
August 06, 2018
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
UNIV KYUSHU NAT UNIV CORP (JP)
International Classes:
G01N33/53; A61K39/395; A61P35/00
Domestic Patent References:
WO2004054616A12004-07-01
Foreign References:
JP2016536314A2016-11-24
JP2015534949A2015-12-07
US20160251436A12016-09-01
JP2017152735A2017-08-31
Other References:
JULIE R. BRAHMER, CHARLES G. DRAKE, IRA WOLLNER, JOHN D. POWDERLY, JOEL PICUS, WILLIAM H. SHARFMAN, ELIZABETH STANKEVICH, ALICE PO: "Phase I Study of Single-Agent Anti–Programmed Death-1 (MDX-1106) in Refractory Solid Tumors: Safety, Clinical Activity, Pharmacodynamics, and Immunologic Correlates", JOURNAL OF CLINICAL ONCOLOGY, AMERICAN SOCIETY OF CLINICAL ONCOLOGY, US, vol. 28, no. 19, 29 March 2008 (2008-03-29), US, pages 3167 - 3175, XP055356706, ISSN: 0732-183X, DOI: 10.1200/JCO.2009.26.7609
BENT W. SIGURSKJOLD: "Exact Analysis of Competition Ligand Binding by Displacement Isothermal Titration Calorimetry", ANALYTICAL BIOCHEMISTRY, ELSEVIER, AMSTERDAM, NL, vol. 277, no. 2, 1 January 2000 (2000-01-01), AMSTERDAM, NL, pages 260 - 266, XP055675164, ISSN: 0003-2697, DOI: 10.1006/abio.1999.4402
See also references of EP 3667318A4
BRAHMER J. R.: "Phase I study of single-agent anti-programmed death-1 (MDX-1106) in refractory solid tumors: safety, clinical activity, pharmacodynamics, and immunologic correlates", J. CLIN. ONCOL., vol. 28, no. 19, 2010, pages 3167 - 3175, XP055124332, DOI: 10.1200/JCO.2009.26.7609
Attorney, Agent or Firm:
TANAI Sumio et al. (JP)
Download PDF: